Clinical trial
Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)
NCT02728778 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)
- Lead sponsor
- Hannover Medical School
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 1, 2016
- Completion date
- October 31, 2019
- Enrollment
- 54 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.